Drug Money: Risky Economy Draws More Clinical Trial Participants

In Yesterday's show, WNYC's Brian Lehrer discussed the rise in Clinical Trials participants with the decline of the American economy.





Forbes/AP also covered this issue.

Do you think that its safe for the industry to see a rise in participants because of the slow economy? With fears that Clinical Trials and organizations could be seen as predators, what precautions should organizations take?